Doheny Eye Institute is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Doheny Eye Institute has participated in 12 clinical trials.
Therapeutic areas: Open-Angle Glaucoma, Ocular Hypertension, Retinitis Pigmentosa.
Sponsors: Allergan, Second Sight Medical Products, ReGenTree, LLC.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Doheny Eye Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Doheny Eye Institute has 12 clinical trials on record. Their work covers Open-Angle Glaucoma, Ocular Hypertension, Retinitis Pigmentosa.
Yes — Doheny Eye Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.